Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sirtuin activation targets IDH-mutant tumors.
Miller JJ, Fink A, Banagis JA, Nagashima H, Subramanian M, Lee CK, Melamed L, Tummala SS, Tateishi K, Wakimoto H, Cahill DP. Miller JJ, et al. Among authors: nagashima h. Neuro Oncol. 2021 Jan 30;23(1):53-62. doi: 10.1093/neuonc/noaa180. Neuro Oncol. 2021. PMID: 32710757 Free PMC article.
IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice.
Richardson LG, Nieman LT, Stemmer-Rachamimov AO, Zheng XS, Stafford K, Nagashima H, Miller JJ, Kiyokawa J, Ting DT, Wakimoto H, Cahill DP, Choi BD, Curry WT. Richardson LG, et al. Among authors: nagashima h. Oncoimmunology. 2020 Aug 20;9(1):1806662. doi: 10.1080/2162402X.2020.1806662. Oncoimmunology. 2020. PMID: 32923170 Free PMC article.
CDKN2A/B homozygous deletion sensitizes IDH-mutant glioma to CDK4/6 inhibition.
Nasser AM, Melamed L, Wetzel E, Chang CC, Nagashima H, Kitagawa Y, Muzyka L, Wakimoto H, Cahill DP, Miller JJ. Nasser AM, et al. Among authors: nagashima h. Clin Cancer Res. 2024 May 8. doi: 10.1158/1078-0432.CCR-24-0562. Online ahead of print. Clin Cancer Res. 2024. PMID: 38718141
1,202 results